CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that David S. Barlow, Chairman and Chief Executive Officer of Molecular Insight Pharmaceuticals, Inc., will present on two occasions at the 10th Annual BIO CEO & Investor Conference at the Waldorf=Astoria Hotel in New York, New York. On February 11, 2008, Mr. Barlow will participate in an opening plenary panel called, “Check Your Options: Raising Public and Private Financing in Today’s Marketplace”, where he will offer his expert insight on the current life sciences financing climate. On February 12, 2008, Mr. Barlow will present an overview of Molecular Insight and its pipeline of molecular radiotherapeutic and molecular imaging pharmaceutical candidates.
